Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × ALT-803 × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Lymphoma, B-Cell 2 Carcinoma, Transitional Cell 2 Urinary Bladder Neoplasms 1 Pancreatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasm, Residual 1 Glioblastoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1

Interventions

Lenalidomide 9 Dexamethasone 8 Bortezomib 6 fludarabine 4 carfilzomib 4 Cyclophosphamide 4 pomalidomide 3 daratumumab 2 belantamab mafodotin 2 Calcium Dobesilate 2 poly ICLC 1 isatuximab 1 fludarabine phosphate 1 elotuzumab 1 citarinostat 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Sirolimus 1 Resistance Training 1 Radiotherapy 1 Prednisone 1 PVX-410 vaccine 1 Mycophenolic Acid 1 Granulocyte Colony-Stimulating Factor 1 Exercise 1 Everolimus 1 Clonal Hematopoiesis 1 Chromatin Immunoprecipitation Sequencing 1 CLR1404 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡